LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation-Reference-Cited by-同舟云学术

LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation

Published:2018-06-13 Issue:41 Volume:37 Page:5534-5551
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Zeng Kaixuan,Chen Xiaoxiang,Hu Xiuxiu,Liu Xiangxiang,Xu Tao,Sun Huiling,Pan Yuqin,He Bangshun,Wang Shukui^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-018-0352-7.pdf

Reference41 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30.

2. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449–60.

3. Peitsaro N, Polianskyte Z, Tuimala J, Porn-Ares I, Liobikas J, Speer O, et al. Evolution of a family of metazoan active-site-serine enzymes from penicillin-binding proteins: a novel facet of the bacterial legacy. BMC Evol Biol. 2008;8:26.

4. Smith TS, Southan C, Ellington K, Campbell D, Tew DG, Debouck C. Identification, genomic organization, and mRNA expression of LACTB, encoding a serine beta-lactamase-like protein with an amino-terminal transmembrane domain. Genomics. 2001;78:12–4.

5. Polianskyte Z, Peitsaro N, Dapkunas A, Liobikas J, Soliymani R, Lalowski M, et al. LACTB is a filament-forming protein localized in mitochondria. Proc Natl Acad Sci USA. 2009;106:18960–5.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LACTB suppresses liver cancer progression through regulation of ferroptosis;Redox Biology;2024-09

2. Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles;Frontiers in Immunology;2024-08-30

3. Recent advances in CRISPR-Cas systems for colorectal cancer research and therapeutics;Expert Review of Molecular Diagnostics;2024-08-02

4. Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma;Journal of Translational Medicine;2024-01-22

5. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy;Molecular Cancer;2024-01-09